VolitionRx issues shares to Lind to satisfy note conversions
VolitionRx converted $525,000 of its senior secured note into common stock across two issuances in September 2026, per an 8-K filing.
SEC filing
Latest
7 stories
Friday, September 25
Tuesday, September 15
VolitionRx issues shares to Lind on convertible note conversions
Two conversions in September 2026 covered $465,000 of obligations under senior secured convertible notes tied to a 2025 purchase agreement.
SEC filing
Wednesday, September 2
VolitionRx gets waiver from Lind on ATM sales exceeding annual cap
Lind Global Asset Management consented to VolitionRx's above-cap ATM sales and waived related default remedies under existing notes and warrants.
SEC filing
Tuesday, September 1
VolitionRx issues shares to Lind Global under convertible note conversions
VolitionRx converted portions of its senior secured convertible notes into common stock across seven transactions dated August 27 and August 31, 2026.
SEC filing
Monday, August 24
VolitionRx issues shares to Lind under existing note conversions
Two share issuances in August 2026 satisfied a combined $400,000 in conversion obligations tied to earlier convertible notes held by Lind Global Asset Management XII.
SEC filing
Thursday, August 13
VolitionRx reports Q2 2026 results, cites licensing talks and Sysmex collaboration
Volition said it is in discussions with more than a dozen diagnostic and liquid biopsy companies on potential licensing deals as it reported second-quarter 2026 results.
SEC filing
Friday, August 7
VolitionRx issues shares to Lind to satisfy note payment and conversion obligations
VolitionRx reported in an 8-K signed August 7, 2026 that it issued shares to Lind Global Asset Management XII LLC to meet payment and conversion terms tied to earlier convertible notes.
SEC filing